CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis
NASDAQ:CCRN • US2274831047
8.35 USD
+0.03 (+0.36%)
Last: Feb 19, 2026, 03:17 PM
CCRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While CCRN has a great health rating, its profitability is only average at the moment. CCRN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year CCRN was profitable.
- CCRN had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
- Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of -2.91%, CCRN is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
- CCRN has a Return On Equity (-3.84%) which is in line with its industry peers.
- The Return On Invested Capital of CCRN (0.98%) is comparable to the rest of the industry.
- The Average Return On Invested Capital over the past 3 years for CCRN is significantly above the industry average of 8.98%.
- The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(0.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROIC | 0.98% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
- CCRN has a Operating Margin of 0.56%. This is comparable to the rest of the industry: CCRN outperforms 40.20% of its industry peers.
- In the last couple of years the Operating Margin of CCRN has declined.
- CCRN's Gross Margin of 20.19% is in line compared to the rest of the industry. CCRN outperforms 44.12% of its industry peers.
- In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCRN is creating some value.
- Compared to 1 year ago, CCRN has less shares outstanding
- CCRN has less shares outstanding than it did 5 years ago.
- There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 4.39 indicates that CCRN is not in any danger for bankruptcy at the moment.
- CCRN has a Altman-Z score of 4.39. This is in the better half of the industry: CCRN outperforms 78.43% of its industry peers.
- CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.39 |
ROIC/WACC0.11
WACC8.69%
2.3 Liquidity
- A Current Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
- CCRN has a Current ratio of 3.45. This is amongst the best in the industry. CCRN outperforms 85.29% of its industry peers.
- A Quick Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
- The Quick ratio of CCRN (3.45) is better than 87.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 |
3. Growth
3.1 Past
- CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -82.86%.
- CCRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.57% yearly.
- Looking at the last year, CCRN shows a very negative growth in Revenue. The Revenue has decreased by -22.14% in the last year.
- The Revenue has been growing by 10.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
3.2 Future
- Based on estimates for the next years, CCRN will show a very negative growth in Earnings Per Share. The EPS will decrease by -33.46% on average per year.
- Based on estimates for the next years, CCRN will show a decrease in Revenue. The Revenue will decrease by -7.58% on average per year.
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- CCRN is valuated quite expensively with a Price/Earnings ratio of 69.58.
- CCRN's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 27.27. CCRN is valued rather expensively when compared to this.
- Based on the Price/Forward Earnings ratio of 69.18, the valuation of CCRN can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of CCRN is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of CCRN to the average of the S&P500 Index (28.16), we can say CCRN is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.58 | ||
| Fwd PE | 69.18 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCRN indicates a rather cheap valuation: CCRN is cheaper than 83.33% of the companies listed in the same industry.
- CCRN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CCRN is cheaper than 93.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.99 | ||
| EV/EBITDA | 7.35 |
4.3 Compensation for Growth
- A cheap valuation may be justified as CCRN's earnings are expected to decrease with -33.46% in the coming years.
PEG (NY)N/A
PEG (5Y)2.83
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
5. Dividend
5.1 Amount
- CCRN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:CCRN (2/19/2026, 3:17:52 PM)
8.35
+0.03 (+0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-04 2026-03-04/amc
Inst Owners96.15%
Inst Owner Change-1.44%
Ins Owners6.14%
Ins Owner Change11.6%
Market Cap273.55M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts71.43
Price Target11.68 (39.88%)
Short Float %4.28%
Short Ratio1.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)-36.67%
EPS NQ rev (1m)-1.41%
EPS NQ rev (3m)-36.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.58 | ||
| Fwd PE | 69.18 | ||
| P/S | 0.24 | ||
| P/FCF | 5.99 | ||
| P/OCF | 5.04 | ||
| P/B | 0.67 | ||
| P/tB | 1.15 | ||
| EV/EBITDA | 7.35 |
EPS(TTM)0.12
EY1.44%
EPS(NY)0.12
Fwd EY1.45%
FCF(TTM)1.39
FCFY16.7%
OCF(TTM)1.66
OCFY19.83%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)2.83
Graham Number5.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROCE | 1.39% | ||
| ROIC | 0.98% | ||
| ROICexc | 1.26% | ||
| ROICexgc | 2.43% | ||
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% | ||
| FCFM | 4.05% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 49.56% | ||
| Cap/Sales | 0.76% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 229.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 | ||
| Altman-Z | 4.39 |
F-Score5
WACC8.69%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year494.68%
EBIT Next 3Y80.04%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
What is the valuation status for CCRN stock?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for CCRN stock?
The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to decline by -76.58% in the next year.